Science rarely hands us plot twists this dramatic—where two of the most feared diseases of our time, cancer and Alzheimer’s, ...

How to watch the Michigan State vs. Louisville second-round game today in the men's NCAA basketball tournament March Madness ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Researchers say they have developed a blood test that can help predict the start of Alzheimer's disease symptoms, allowing ...

Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of ...

(WHTM) — A global campaign is marking Brain Awareness Week through Sunday, and Penn State professors are explaining some of the science behind the brain. “100 years ago, we had very crude technology.

Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...

New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein buildup.

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s Research, Care, and Services.

Findings underpin potential of Anavex’ lead candidate blarcamesine through its upstream mechanism of action and SIGMAR1-mediated autophagy restoration ...